Results of a phase II study investigating Pembrolizumab for treatment of relapsed Mycosis Fungoides or Sezary Syndrome.
Home / Resource Library / Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sezary Syndrome: A Multicenter Phase II Study